Zopiclone(CAS?43200-80-2) is a nonbenzodiazepine used to treat difficulty sleeping.
Zopiclone API Market contains market size and forecasts of Zopiclone API in global, including the following market information:
- Global Zopiclone API Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Zopiclone API Market Sales, 2018-2023, 2023-2030, (Kg)
Global top five Zopiclone API companies in 2022 (%)
The global Zopiclone API market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Above 98 % Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Zopiclone API include Otto Brandes, CHEMO, EUROAPI, Jubilant Generics, FARMAK, Centaur Pharmaceuticals, Calyx Chemicals & Pharmaceuticals Limited, Grindeks AS and Asia Pioneer Pharmaceuticals, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Zopiclone API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zopiclone API Market, by Purity, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Zopiclone API Market Segment Percentages, by Purity, 2022 (%)
Global Zopiclone API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Zopiclone API Market Segment Percentages, by Application, 2022 (%)
Global Zopiclone API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Zopiclone API Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Zopiclone API revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Zopiclone API revenues share in global market, 2022 (%)
- Key companies Zopiclone API sales in global market, 2018-2023 (Estimated), (Kg)
- Key companies Zopiclone API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Otto Brandes
- CHEMO
- EUROAPI
- Jubilant Generics
- FARMAK
- Centaur Pharmaceuticals
- Calyx Chemicals & Pharmaceuticals Limited
- Grindeks AS
- Asia Pioneer Pharmaceuticals
- Sagami Chemical Industry